SK280546B6 - Deriváty kyseliny 8-oxo-5,8-dihydro-6h-dibenzo[a,g - Google Patents

Deriváty kyseliny 8-oxo-5,8-dihydro-6h-dibenzo[a,g Download PDF

Info

Publication number
SK280546B6
SK280546B6 SK1658-95A SK165895A SK280546B6 SK 280546 B6 SK280546 B6 SK 280546B6 SK 165895 A SK165895 A SK 165895A SK 280546 B6 SK280546 B6 SK 280546B6
Authority
SK
Slovakia
Prior art keywords
formula
group
ester
dibenzo
quinolizine
Prior art date
Application number
SK1658-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK165895A3 (en
Inventor
Benoit Marabout
Mireille Sevrin
Jacques Froissant
Emmanuelle Dachary
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of SK165895A3 publication Critical patent/SK165895A3/sk
Publication of SK280546B6 publication Critical patent/SK280546B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1658-95A 1994-12-29 1995-12-28 Deriváty kyseliny 8-oxo-5,8-dihydro-6h-dibenzo[a,g SK280546B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415836A FR2728902B1 (fr) 1994-12-29 1994-12-29 Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
SK165895A3 SK165895A3 (en) 1996-07-03
SK280546B6 true SK280546B6 (sk) 2000-03-13

Family

ID=9470389

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1658-95A SK280546B6 (sk) 1994-12-29 1995-12-28 Deriváty kyseliny 8-oxo-5,8-dihydro-6h-dibenzo[a,g

Country Status (26)

Country Link
US (1) US5614517A (de)
EP (1) EP0719776B1 (de)
JP (1) JPH08239383A (de)
KR (1) KR960022518A (de)
CN (1) CN1058009C (de)
AR (1) AR002015A1 (de)
AT (1) ATE172973T1 (de)
AU (1) AU697988B2 (de)
BR (1) BR9506105A (de)
CA (1) CA2166233A1 (de)
CO (1) CO4700297A1 (de)
CZ (1) CZ348895A3 (de)
DE (1) DE69505781T2 (de)
DK (1) DK0719776T3 (de)
ES (1) ES2126232T3 (de)
FI (1) FI956299A (de)
FR (1) FR2728902B1 (de)
HU (1) HU215393B (de)
IL (1) IL116596A (de)
NO (1) NO305084B1 (de)
NZ (1) NZ280766A (de)
PL (1) PL181811B1 (de)
RU (1) RU2155764C2 (de)
SK (1) SK280546B6 (de)
TW (1) TW385311B (de)
ZA (1) ZA9511035B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806723B1 (fr) * 2000-03-23 2002-05-10 Sanofi Synthelabo DERIVES D'ACIDE 8-OXO-5,8-DIHYDRO-6H-DIBENZO [a,g] QUINOLIZINE-13-PROPANOIQUE , LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
CN104127414B (zh) * 2013-05-03 2018-04-13 中国科学院上海药物研究所 一种六氢二苯并[a,g]喹嗪类化合物的药物用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013616A (en) * 1971-11-22 1977-03-22 Wallace Richard A Mixed polymeric structural material and method

Also Published As

Publication number Publication date
CZ348895A3 (en) 1996-07-17
HUT74186A (en) 1996-11-28
TW385311B (en) 2000-03-21
AR002015A1 (es) 1998-01-07
BR9506105A (pt) 1997-12-23
NO305084B1 (no) 1999-03-29
ZA9511035B (en) 1996-07-01
JPH08239383A (ja) 1996-09-17
NO955325D0 (no) 1995-12-28
ATE172973T1 (de) 1998-11-15
HU9503846D0 (en) 1996-02-28
DE69505781T2 (de) 1999-06-17
AU4070895A (en) 1996-07-04
FI956299A0 (fi) 1995-12-28
NO955325L (no) 1996-07-01
CN1131154A (zh) 1996-09-18
SK165895A3 (en) 1996-07-03
ES2126232T3 (es) 1999-03-16
CA2166233A1 (en) 1996-06-30
EP0719776B1 (de) 1998-11-04
US5614517A (en) 1997-03-25
RU2155764C2 (ru) 2000-09-10
CN1058009C (zh) 2000-11-01
IL116596A0 (en) 1996-03-31
NZ280766A (en) 1996-09-25
KR960022518A (ko) 1996-07-18
PL312080A1 (en) 1996-07-08
DK0719776T3 (da) 1999-07-19
DE69505781D1 (de) 1998-12-10
IL116596A (en) 1998-10-30
EP0719776A1 (de) 1996-07-03
FI956299A (fi) 1996-06-30
PL181811B1 (pl) 2001-09-28
FR2728902B1 (fr) 1997-01-31
HU215393B (hu) 1998-12-28
AU697988B2 (en) 1998-10-22
FR2728902A1 (fr) 1996-07-05
CO4700297A1 (es) 1998-12-29

Similar Documents

Publication Publication Date Title
SK15612002A3 (sk) Azabicyklické karbamáty, spôsob ich prípravy a farmaceutické prostriedky, ktoré ich obsahujú ako účinné látky
WO1996028446A1 (en) SUBSTITUTED N-CYCLOALKYLMETHYL-1H-PYRAZOLO[3,4-b]QUINOLIN-4 AMINES AND COMPOSITIONS AND METHODS OF USE THEREOF
SK165795A3 (en) 3-phenylizoquinoline-1(2h)-one derivatives, preparation method and pharmaceutical compounds containing these derivatives
SK34196A3 (en) Piperidine derivatives, preparation method thereof, piperidine derivatives as medicaments and pharmaceutical compositions containing these derivatives
US6703391B2 (en) Quinoxalinedione derivatives, their preparation and use
EP0375210A1 (de) Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
FI88162B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara sulfonyldekahydro-8h-isokino/2,1-g//1,6/naftyridiner, deras optiska isomerer samt farmaceutiskt godtagbara salter
PL191091B1 (pl) Nowe związki indanolowe, zawierające je kompozycje farmaceutyczne oraz ich zastosowanie
SK280546B6 (sk) Deriváty kyseliny 8-oxo-5,8-dihydro-6h-dibenzo[a,g
AU2114600A (en) Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors
PL184412B1 (pl) Nowe pochodne 3,3a,4,5-tetrahydro-1H-oksazolo [3,4-a] chinolin-1-onu, sposób ich wytwarzania i preparat farmaceutyczny
WO1987002035A1 (en) Fused cycloaliphatic aminoalcohols
JPS6147487A (ja) オクタヒドロ‐オキサゾロ［４，５‐ｇ］キノリン
AU597936B2 (en) Tetracyclic quinazolin derivatives
JPS624250A (ja) ベンズ三置換−２−アミノテトラリン
US4123545A (en) N-Propyl-3(β-hydroxyethyl)-3-(meta-hydroxyphenyl)-pyrrolidine
FR2759698A1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
JPH03118361A (ja) ピロリジン誘導体